Table 2.
Methodological quality of included randomized clinical trials
| First author, year[Ref.] | Generation of allocation sequence | Allocation concealment | Blinding | Methodologicalquality |
| Han, 2010[22] | Unclear | Unclear | Unclear | Low |
| Zhang, 2010[21] | Unclear | Unclear | Unclear | Low |
| Han, 2009[23] | Unclear | Unclear | Unclear | Low |
| Su, 2009[24] | Unclear | Unclear | Unclear | Low |
| Xu, 2009[25] | Unclear | Adequate | Adequate | High |
| Shi, 2009[26] | Adequate | Adequate | Adequate | High |
| Yang, 2008[27] | Adequate | Unclear | Unclear | Low |
| Guo, 2008[28] | Adequate | Unclear | Unclear | Low |
| Xiang, 2007[29] | Adequate | Unclear | Unclear | Low |
| Feng, 2007[30] | Not done | Not done | Not done | Low |
| Li, 2006[31] | Not done | Not done | Not done | Low |
| Li, 2006[32] | Not done | Not done | Not done | Low |
| Han, 2005[33] | Not done | Not done | Not done | Low |
| Shi, 2005[34] | Adequate | Unclear | Unclear | Low |
| Li, 2003[35] | Adequate | Unclear | Unclear | Low |